Wealth Enhancement Advisory Services LLC Raises Stock Position in DaVita Inc. (NYSE:DVA)

Wealth Enhancement Advisory Services LLC raised its stake in shares of DaVita Inc. (NYSE:DVA) by 22.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,351 shares of the company’s stock after buying an additional 800 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in DaVita were worth $666,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Sanctuary Advisors LLC bought a new position in DaVita in the fourth quarter valued at about $180,000. Smartleaf Asset Management LLC increased its position in shares of DaVita by 16.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 712 shares of the company’s stock valued at $107,000 after purchasing an additional 101 shares during the last quarter. Jones Financial Companies Lllp lifted its stake in shares of DaVita by 28.6% in the 4th quarter. Jones Financial Companies Lllp now owns 517 shares of the company’s stock worth $77,000 after purchasing an additional 115 shares during the period. SBI Securities Co. Ltd. purchased a new position in shares of DaVita in the fourth quarter worth approximately $41,000. Finally, Keybank National Association OH grew its position in DaVita by 4.7% during the fourth quarter. Keybank National Association OH now owns 2,721 shares of the company’s stock valued at $407,000 after buying an additional 121 shares during the period. 90.12% of the stock is owned by institutional investors.

DaVita Stock Performance

DaVita stock opened at $142.56 on Friday. DaVita Inc. has a 1 year low of $131.76 and a 1 year high of $179.60. The firm’s 50 day moving average price is $140.00 and its 200-day moving average price is $149.27. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20. The stock has a market cap of $10.76 billion, a P/E ratio of 14.13, a PEG ratio of 0.98 and a beta of 1.11.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Monday, May 12th. The company reported $2.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.75 by $0.25. DaVita had a net margin of 6.63% and a return on equity of 176.11%. The company had revenue of $3.22 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same period in the previous year, the firm posted $2.26 EPS. DaVita’s revenue for the quarter was up 5.0% compared to the same quarter last year. On average, equities analysts predict that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have commented on DVA. Wall Street Zen raised shares of DaVita from a “hold” rating to a “buy” rating in a report on Friday, April 25th. Truist Financial decreased their target price on DaVita from $170.00 to $164.00 and set a “hold” rating on the stock in a report on Monday, May 19th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, DaVita has an average rating of “Hold” and a consensus price target of $164.50.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.